This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Rousselot B.v. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Elien Monique Gevaert: Innovator in Collagen Research
Introduction
Elien Monique Gevaert is a notable inventor based in Ghent, Belgium. She has made significant contributions to the field of collagen research, focusing on its applications in health and nutrition. With a total of 2 patents, her work is paving the way for innovative solutions in medical and dietary supplements.
Latest Patents
Gevaert's latest patents include a formulation of hydrolyzed collagen aimed at reducing blood glucose levels. This invention involves enzymatic hydrolysis of collagen-containing materials using a combination of enzymes, making it particularly suitable as a food supplement for ameliorating hyperglycemia. Another significant patent focuses on collagen hydrolysate for the prevention and treatment of post-intensive care syndrome (PICS). This formulation is designed to improve recovery after an ICU stay and is considered safe for long-term use.
Career Highlights
Elien Monique Gevaert is currently associated with Rousselot B.V., a company known for its expertise in collagen-based products. Her work at Rousselot has allowed her to explore the therapeutic potentials of collagen, contributing to advancements in both medical and nutritional fields.
Collaborations
Gevaert collaborates with talented professionals in her field, including Janne Prawitt and Praneeth Reddy Kuninty. These collaborations enhance her research and development efforts, leading to innovative solutions in collagen applications.
Conclusion
Elien Monique Gevaert is a pioneering inventor whose work in collagen research is making a significant impact on health and nutrition. Her patents reflect her commitment to improving health outcomes through innovative formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile